Screening of natural compounds for inhibitory activity on colon cancer cell migration

被引:57
作者
Ogasawara, M [1 ]
Matsubara, T [1 ]
Suzuki, H [1 ]
机构
[1] Toyama Prefectural Inst Pharmaceut Res, Toyama 9390363, Japan
关键词
colon cancer; migration; evodiamine; paclitaxel; low cytotoxicity;
D O I
10.1248/bpb.24.720
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We examined the effects of 75 kinds of natural compounds, such as alkaloids, phenylpropanoids, flavonoids, steroids and terpenoids on the in vitro migration and proliferation of colon 26-L5 cells, in comparison with anticancer drugs used for chemotherapy. Twenty-three of the 75 compounds inhibited markedly tumor cell migration. Among the 23 compounds, evodiamine showed the most potent and selective inhibitory activity on tumor cell migration with an IC50 value of 1.25 mug/ml, which was about 20 times lower than that for tumor cell proliferation. The migratory inhibition reached about 70% at 10 mug/ml of evodiamine. On the other hand, most of anticancer drugs tested, except for paclitaxel, had little effect on tumor cell migration at the concentrations strongly inhibiting tumor cell proliferation. Paclitaxel suppressed tumor cell migration in a concentration-dependent manner and achieved about 70% inhibition at 10 mug/ml with a marginal effect on cell proliferation. These results suggest that evodiamine and paclitaxel may be regarded as leading compounds for anti-metastatic agents acting through the inhibition of tumor cell migration without cytotoxicity.
引用
收藏
页码:720 / 723
页数:4
相关论文
共 26 条
  • [1] Alessandro R, 1996, IN VIVO, V10, P153
  • [2] Ata N, 1996, ONCOL RES, V8, P503
  • [3] Belotti D, 1996, CLIN CANCER RES, V2, P1725
  • [4] Clinical targets for anti-metastasis therapy
    Chambers, AF
    MacDonald, IC
    Schmidt, EE
    Morris, VL
    Groom, AC
    [J]. ADVANCES IN CANCER RESEARCH, VOL 79, 2000, 79 : 91 - +
  • [5] THE VASORELAXANT EFFECT OF EVODIAMINE IN RAT ISOLATED MESENTERIC-ARTERIES - MODE OF ACTION
    CHIOU, WF
    CHOU, CJ
    SHUM, AYC
    CHEN, CF
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 215 (2-3) : 277 - 283
  • [6] Horwitz S. B., 1994, ANN ONCOL, V5, pS3, DOI DOI 10.1093/ANN0NC/5.SUPPL_4.S3
  • [7] A SYNTHETIC PEPTIDE FROM FIBRONECTIN INHIBITS EXPERIMENTAL METASTASIS OF MURINE MELANOMA-CELLS
    HUMPHRIES, MJ
    OLDEN, K
    YAMADA, KM
    [J]. SCIENCE, 1986, 233 (4762) : 467 - 470
  • [8] An essential part for Rho-associated kinase in the transcellular invasion of tumor cells
    Itoh, K
    Yoshioka, K
    Akedo, H
    Uehata, M
    Ishizaki, T
    Narumiya, S
    [J]. NATURE MEDICINE, 1999, 5 (02) : 221 - 225
  • [9] The matrix metalloproteinases and their inhibitors in the treatment of pancreatic cancer
    Jones, L
    Ghaneh, P
    Humphreys, M
    Neoptolemos, JP
    [J]. CELL AND MOLECULAR BIOLOGY OF PANCREATIC CARCINOMA: RECENT DEVELOPMENTS IN RESEARCH AND EXPERIMENTAL THERAPY, 1999, 880 : 288 - 307
  • [10] KOHN EC, 1995, CANCER RES, V55, P1856